| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
261,565 |
310,203 |
401,165 |
779,048 |
| Total Sell Value |
$100,839,669 |
$114,309,929 |
$143,376,644 |
$237,969,083 |
| Total People Sold |
9 |
9 |
12 |
12 |
| Total Sell Transactions |
24 |
29 |
41 |
68 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rubash Mark J |
Director |
– • – |
2023-04-21 |
4 |
OE |
$90.49 |
$1,134,862 |
D/D |
8,135 |
15,927 |
|
- |
|
| Rosa David J. |
EVP Chief Strategy & Growth Of |
• – – |
2023-04-21 |
4 |
AS |
$297.92 |
$12,155,173 |
D/D |
(40,800) |
142,476 |
|
- |
|
| Rosa David J. |
EVP Chief Strategy & Growth Of |
• – – |
2023-04-21 |
4 |
OE |
$42.64 |
$2,302,382 |
D/D |
54,000 |
183,276 |
|
- |
|
| Desantis Robert |
EVP & Chief Product Officer |
• – – |
2023-04-21 |
4 |
AS |
$297.90 |
$2,568,981 |
D/D |
(8,623) |
7,065 |
|
- |
|
| Desantis Robert |
EVP & Chief Product Officer |
• – – |
2023-04-21 |
4 |
OE |
$177.99 |
$1,407,768 |
D/D |
6,260 |
11,872 |
|
- |
|
| Barratt Craig H |
Director |
– • – |
2023-04-21 |
4 |
AS |
$297.92 |
$1,787,524 |
D/D |
(6,000) |
0 |
|
- |
|
| Barratt Craig H |
Director |
– • – |
2023-04-21 |
4 |
OE |
$41.26 |
$247,547 |
D/D |
6,000 |
2,000 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2023-04-21 |
4 |
AS |
$297.92 |
$2,884,579 |
D/D |
(9,623) |
327 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2023-04-21 |
4 |
OE |
$166.62 |
$1,378,787 |
D/D |
8,000 |
7,950 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2023-04-21 |
4 |
AS |
$297.89 |
$501,401 |
D/D |
(1,683) |
15,000 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2023-04-21 |
4 |
OE |
$71.32 |
$128,913 |
D/D |
1,683 |
15,349 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2023-03-01 |
4 |
AS |
$228.47 |
$286,273 |
D/D |
(1,253) |
1,950 |
|
- |
|
| Charlton Henry L |
Senior Vice President & Chief |
• – – |
2023-02-28 |
4 |
D |
$229.39 |
$170,666 |
D/D |
(744) |
20,516 |
|
- |
|
| Charlton Henry L |
Senior Vice President & Chief |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,201 |
20,743 |
|
- |
|
| Samath Jamie |
Chief Financial Officer |
• – – |
2023-02-28 |
4 |
D |
$229.39 |
$159,655 |
D/D |
(696) |
6,127 |
|
- |
|
| Samath Jamie |
Chief Financial Officer |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,009 |
6,388 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2023-02-28 |
4 |
D |
$229.39 |
$344,314 |
D/D |
(1,501) |
3,203 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,259 |
3,701 |
|
- |
|
| Mohr Marshall |
Executive VP Global Business S |
• – – |
2023-02-28 |
4 |
D |
$229.39 |
$370,924 |
D/D |
(1,617) |
24,136 |
|
- |
|
| Mohr Marshall |
Executive VP Global Business S |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,259 |
24,634 |
|
- |
|
| Widman Fredrik |
VP Corporate Controller |
• – – |
2023-02-28 |
4 |
D |
$229.39 |
$104,602 |
D/D |
(456) |
2,863 |
|
- |
|
| Widman Fredrik |
VP Corporate Controller |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,317 |
3,025 |
|
- |
|
| Desantis Robert |
EVP & Chief Product Officer |
• – – |
2023-02-28 |
4 |
D |
$229.39 |
$391,110 |
D/D |
(1,705) |
9,428 |
|
- |
|
| Desantis Robert |
EVP & Chief Product Officer |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,679 |
10,125 |
|
- |
|
| Rosa David J. |
EVP Chief Strategy & Growth Of |
• – – |
2023-02-28 |
4 |
D |
$229.39 |
$427,812 |
D/D |
(1,865) |
129,276 |
|
- |
|
1324 Records found
|
|
Page 7 of 53 |
|
|
5.92 (1.56%) 
